GlassScriptPhysician profile
Sara Mateen
NPI 1194216705
$14,682.49
in general payments reported to CMS, 2019-2025
19 companies · $329 in 2025
The $329 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,332 · 2020: $170 · 2021: $2,965 · 2022: $5,033 · 2023: $4,282 · 2024: $571 · 2025: $329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,077 · Food and Beverage: $2,106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,076.82 |
| Food and Beverage | $2,105.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $3,361.55 | 2021-2025 | Truelok, Physio-Stim |
| Medical Device Business Services, INC. | $2,963.73 | 2020-2023 | Na |
| Liberty Surgical INC. | $2,588.76 | 2019-2022 | |
| Arthrex, INC. | $1,736.05 | 2022-2023 | |
| Depuy Synthes Sales INC. | $872.94 | 2021-2025 | Na, Vivigen Mis Delivery System, Orthovisc |
| Supreme Orthopedic Systems, LLC | $763.71 | 2021-2023 | |
| Paragon 28, INC. | $705.59 | 2022-2024 | Monkey Rings, Bun-Yo-Matic |
| Stryker Corporation | $386.15 | 2022-2024 | Ortholoc 3di, Gravity Synchfix, Citrefix |
| Sanara Medtech INC. | $342.99 | 2022-2024 | Celleraterx |
| Musculoskeletal Transplant Foundation INC. | $168.20 | 2023 | |
| Nuvasive Specialized Orthopedics, INC. | $163.94 | 2022 | |
| Bioventus LLC | $148.77 | 2022 | |
| Aroa Biosurgery Incorporated | $141.90 | 2022 | |
| Axogen | $138.33 | 2025 | |
| Treace Medical Concepts, INC. | $75.70 | 2024-2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $56.06 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Seapearl East, INC | $34.30 | 2025 | |
| Novastep INC. | $17.01 | 2021 | |
| Averitas Pharma INC. | $16.81 | 2023 | Qutenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Mateen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.